FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Mann Michael Scott 		2. Issuer Name and Ticker or Trading Symbol

ENDONOVO THERAPEUTICS, INC. [ ENDV ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
President
(Last)          (First)          (Middle)

6320 CANOGA AVENUE 		3. Date of Earliest Transaction (MM/DD/YYYY)

10/29/2018
(Street)

WOODLAND HILLS, CA 91367
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   10/29/2018     P    2000   A $0.0426   26092498   D    
Common Stock   10/30/2018     P    1000   A $0.041   26093498   D    
Common Stock   10/30/2018     P    2000   A $0.0408   26095498   D    
Common Stock   10/31/2018     P    2000   A $0.0433   26097498   D    
Common Stock   10/31/2018     P    1000   A $0.0399   26098498   D    
Common Stock   10/31/2018     P    1000   A $0.0395   26099498   D    
Common Stock   10/31/2018     P    1000   A $0.0392   26100498   D    
Common Stock   10/31/2018     P    1000   A $0.0395   26101498   D    
Common Stock   10/31/2018     P    2000   A $0.0392   26103498   D    
Common Stock   10/31/2018     P    1000   A $0.036   26104498   D    
Common Stock   10/31/2018     P    1000   A $0.0375   26105498   D    
Common Stock   10/31/2018     P    1000   A $0.0382   26106498   D    
Common Stock   10/31/2018     P    2000   A $0.039   26108498   D    
Common Stock   10/31/2018     P    2000   A $0.0382   26110498   D    
Common Stock   10/31/2018     P    1000   A $0.0386   26111498   D    
Common Stock   10/31/2018     P    1000   A $0.041   26112498   D    
Common Stock   10/31/2018     P    1000   A $0.0412   26113498   D    
Common Stock   10/31/2018     P    5000   A $0.0358   26118498   D    
Common Stock   10/31/2018     P    1000   A $0.0358   26119498   D    
Common Stock   10/31/2018     P    1000   A $0.0356   26120498   D    
Common Stock   10/31/2018     P    1000   A $0.0356   26121498   D    
Common Stock   11/1/2018     P    1000   A $0.04   26122498   D    
Common Stock   11/1/2018     P    1000   A $0.038   26123498   D    
Common Stock   11/1/2018     P    1000   A $0.0377   26124498   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Mann Michael Scott
6320 CANOGA AVENUE
WOODLAND HILLS, CA 91367

President

Signatures
Michael Scott Mann 11/2/2018
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.